Asian Medecine news

Medecine

Net Sales for the 12 months ended March 2017 grew by 7.9 per cent, the Board recommends a final dividend of Rs 25/- per share The post Clariant announced its financial results for the year ended March 31, 2017 appeared first on …
05.24 / 22:39
financialexpress.com
Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis The post Sun Pharma received US FDA acceptance of BLA for Tildrakizumab appeared first on …
05.24 / 22:39
financialexpress.com
During FY 2016-2017 total income stood at ₹ 726.4 crore in comparison to ₹ 770.8 crore recorded in the previous corresponding period. Board recommends dividend of ₹ 10 per equity share of ₹5 each At a meeting held in Mumbai, the Board of Novartis India approved results for the quarter and financial year ended March […] The post Novartis India announces results for the quarter and year ended March 31, 2017 appeared first on BPD…
05.24 / 22:39
financialexpress.com
It is a monoclonal antibody developed for the treatment of solid tumours soft tissue sarcomas GNH India, pharmaceutical wholesaler, has imported a life-saving medicine called Olaratumab, trade name Lartruvo, that is now available through official import channels. Reportedly, it is a monoclonal antibody developed by Eli Lilly for the treatment of solid tumours. It is […] The post GNH imports Olaratumab to India appeared first on …
05.24 / 22:39
financialexpress.com